High-end research and top-class medicine are closely related. Patients who seek treatment in Berlin benefit from the fact that hospitals quickly incorporate new products and procedures into their everyday routines. This is thanks to close cooperation between hospitals and the city’s thriving research scene and numerous biotech and medical technology companies.
Currently, 35 major research institutions and universities are working in the field of life sciences in the German capital. They include the internationally renowned Max Delbrück Center for Molecular Medicine, the Fraunhofer and Max Planck institutes and the institutes of the Helmholtz and Leibniz associations. In 2013, the Charité and Max Delbrück Center established a biomedical research institution, the Berlin Institute of Health (BIH). Its goal is to ensure that research findings from the life sciences are implemented in a quicker and more targeted manner for the benefit of patients.
In recent years, the outstanding scientific environment and wide-ranging clinical research scene have prompted more and more global pharmaceutical companies to base themselves in Berlin. Numerous creative start-ups are also implementing their innovative projects in Berlin, shaping the future of medical care.